CARDIFF LEXINGTON CORPORATION

CDIX ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $2.2M $1.6M $1.2M $1.4M $890.4K $0 $839 $262
Cost of Revenue $1.5M $1.4M $404.5K $862.8K $618.3K $0 $0
Gross Profit $755.8K $193.9K $353.2K $391.9K $236.5K $0 $262
Gross Margin 33.9% 11.9% 30.7% 28.2% 26.6% 100.0%
Operating Expenses
Research & Development
SG&A Expense $2.8M $2.1M $2.5M
Operating Income $-2.0M $-3.0M $-2.2M $-3.9M $-12.5M $-11.0M $-819.2K $-1.1M
Operating Margin -90.8% -184.1% -188.2% -281.4% -1,398.6% -97,643.6% -415,680.2%
Interest Expense $329.0K $111.7K $48.8K $32.1K $61.1K $505.6K $521.4K $906.6K
Pretax Income
Income Tax Expense
Net Income $-6.3M $-3.7M $-2.3M $-3.9M $-13.1M $-11.0M $596.2K $-2.8M
Net Margin -281.3% -224.6% -196.0% -283.9% -1,474.8% 71,066.2% -1,081,988.9%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 4.66T 510.79T 195.13T 59.13T 62.42T 62.25T 239,993.86T 179,223.12T
Shares Outstanding (Diluted) 4.66T 510.79T 195.13T 59.13T 62.42T 62.25T 247,547.17T 179,223.12T
Dividends Per Share
← Newer Page 2 of 4 Older →